What is the recommended dosing regimen for Eylea?

What is the recommended dosing regimen for Eylea?

• A. One injection every month
• B. One injection every 2 months
• C. One injection every 6 weeks
• D. One injection every 3 months

Answer: (B)

The recommended dosing regimen for Eylea (aflibercept) in the treatment of conditions like age-related macular degeneration (AMD) typically begins with a loading phase that involves one injection per month for the first three months, after which the interval can generally be extended. Following this initial loading phase, the common practice is to administer one injection every two months as a maintenance dose. This regimen is based on clinical studies showing that extending the interval to every two months allows for effective management of the condition while also providing flexibility for the patient's treatment plan. The transition from monthly to bi-monthly dosing enhances adherence and helps to reduce treatment burden without compromising efficacy. The knowledge of this regimen is essential for healthcare professionals to provide appropriate patient care in managing AMD and related conditions effectively.

The recommended dosing regimen for Eylea (aflibercept) in the treatment of conditions like age-related macular degeneration (AMD) typically begins with a loading phase that involves one injection per month for the first three months, after which the interval can generally be extended. Following this initial loading phase, the common practice is to administer one injection every two months as a maintenance dose.

This regimen is based on clinical studies showing that extending the interval to every two months allows for effective management of the condition while also providing flexibility for the patient's treatment plan. The transition from monthly to bi-monthly dosing enhances adherence and helps to reduce treatment burden without compromising efficacy. The knowledge of this regimen is essential for healthcare professionals to provide appropriate patient care in managing AMD and related conditions effectively.